Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication

Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder caused by circulating autoantibodies (inhibitor) directed against coagulation factor VIII (FVIII). We report a 39-year-old single female who presented to emergency department with sudden onset gross hematuria 10 days following her fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Dina Sameh, Al Battah, Afaf, Al Faridi, Dekra, Ibrahim, Feryal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827248/
https://www.ncbi.nlm.nih.gov/pubmed/35211227
http://dx.doi.org/10.14740/jmc3827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827248/
https://www.ncbi.nlm.nih.gov/pubmed/35211227
http://dx.doi.org/10.14740/jmc3827

Ejemplares similares